Viewing Study NCT04382950


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2025-12-25 @ 2:36 PM
Study NCT ID: NCT04382950
Status: UNKNOWN
Last Update Posted: 2021-06-09
First Post: 2020-05-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications
Sponsor: Kafrelsheikh University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module